申请人:FISHER Peter Martin
公开号:US20090270427A1
公开(公告)日:2009-10-29
The present invention relates to compounds of formula 1
or pharmaceutically acceptable salts thereof, wherein
one of R
1
and R
2
is methyl, ethyl or isopropyl, and the other is H;
R
3
and R
4
are each independently H, branched or unbranched C
1
-C
6
alkyl, or aryl, and wherein at least one of R
3
and R
4
is other than H;
R
5
is a branched or unbranched C
1
-C
5
alkyl group or a C
1
-C
6
cycloalkyl group, each of which may be optionally substituted with one or more OH groups;
R
6
, R
7
, R
8
and R
9
are each independently H, halogen, NO
2
, OH, OMe, CN, NH
2
, COOH, CONH
2
, or SO
2
NH
2
.
A further aspect of the invention relates to pharmaceutical compositions comprising compounds of formula 1, and the use of said compounds in treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative disorders.
本发明涉及公式1的化合物或其药学上可接受的盐,其中R1和R2中的一个是甲基、乙基或异丙基,另一个是氢;R3和R4各自独立地是氢、支链或直链C1-C6烷基或芳基,其中至少有一个R3和R4不是氢;R5是支链或直链C1-C5烷基或C1-C6环烷基,每个基团都可以选择性地取代一个或多个OH基团;R6、R7、R8和R9各自独立地是氢、卤素、NO2、OH、OMe、CN、NH2、COOH、CONH2或SO2NH2。本发明的另一个方面涉及包含公式1化合物的药物组合物,以及使用所述化合物治疗增殖性疾病、病毒性疾病、中枢神经系统疾病、糖尿病、中风、脱发或神经退行性疾病的用途。